Cite
Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial
MLA
Charlotte Hautefort, et al. “Local Budesonide Therapy in the Management of Persistent Hyposmia in Suspected Non-Severe COVID-19 Patients: Results of a Randomized Controlled Trial.” International Journal of Infectious Diseases, vol. 136, no. 70–76, Nov. 2023, pp. 70–76. EBSCOhost, https://doi.org/10.1016/j.ijid.2023.08.022.
APA
Charlotte Hautefort, Alain Corré, Guillaume Poillon, Clément Jourdaine, Juliette Housset, Michael Eliezer, Benjamin Verillaud, Dorsaf Slama, Denis Ayache, Philippe Herman, Amélie Yavchitz, Jessica Guillaume, Camille Hervé, Wissame El Bakkouri, Dominique Salmon, & Mary Daval. (2023). Local budesonide therapy in the management of persistent hyposmia in suspected non-severe COVID-19 patients: Results of a randomized controlled trial. International Journal of Infectious Diseases, 136(70–76), 70–76. https://doi.org/10.1016/j.ijid.2023.08.022
Chicago
Charlotte Hautefort, Alain Corré, Guillaume Poillon, Clément Jourdaine, Juliette Housset, Michael Eliezer, Benjamin Verillaud, et al. 2023. “Local Budesonide Therapy in the Management of Persistent Hyposmia in Suspected Non-Severe COVID-19 Patients: Results of a Randomized Controlled Trial.” International Journal of Infectious Diseases 136 (70–76): 70–76. doi:10.1016/j.ijid.2023.08.022.